ArticleClinical rheumatology2026
Predictive modeling of cardiovascular risk in systemic sclerosis: a single-center retrospective study integrating clinical and imaging data.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundCardiovascular disease (CVD) is a leading cause of mortality in systemic sclerosis (SSc). Early risk identification is crucial for improving prognosis.
objectivesThe aim of this study was to develop a clinical prediction model for assessing cardiovascular disease risk in SSc patients via integrating clinical and imaging data.
methodsWe retrospectively analyzed the occurrence of CVD among 245 SSc patients and 245 controls. SSc patients were stratified by CVD event. Independent predictors of CVD risk were identified using Cox regression analysis in SSc patients. Receiver operator characteristic (ROC) curves assessed the model's predictive performance. Kaplan-Meier (KM) curves evaluated the association of these factors with event-free survival.
resultsSSc patients exhibited significantly higher CVD events than controls. Significant differences were observed between SSc patients with and without events regarding age, sex, disease duration, modified Rodnan skin score (mRSS), erythrocyte sedimentation rate (ESR), anti-Scl-70 antibody (ATA), anti-U3 RNP, pulmonary arterial hypertension (PAH), interstitial lung disease (ILD), coronary artery calcium score (CACS) and epicardial adipose tissue (EFV). Cox regression identified CACS, mRSS, EFV, and ATA as independent predictors of increased CVD risk. The combined model (CACS, EFV, mRSS, ATA) achieved an area under the curve (AUC) of 0.910, showing high accuracy for predicting CVD events in SSc. KM analysis confirmed significantly reduced event-free survival in patients with high CACS, high mRSS, ATA positivity, or high EFV (all P < 0.05).
conclusionCACS, mRSS, EFV, and ATA are independent risk factors for CVD events in SSc patients. A model combining these factors effectively predicts CVD incidence in this population. Key Points • CACS, mRSS, EFV, and ATA were identified as independent predictors of cardiovascular events. • The combination of CACS, EFV, mRSS, and ATA yielded a high AUC of 0.910, demonstrating strong predictive capability with high specificity and sensitivity for cardiovascular events in SSc individuals.
Indexed as
Identifiers
41291378What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.